GLP-1 receptor agonist drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide are praised for their appetite-suppressing effects and impressive short-term weight-loss outcomes
Do not tolerate the side effects : Some people experience nausea, vomiting, or stomach pain when taking semaglutide, making it difficult to continue the medication
The most commonly prescribed options include Semaglutide (marketed as Wegovy or Ozempic) and Liraglutide (marketed as Saxenda), which differ in dosing frequency and strength
Treatment evolves as progress is made, ensuring that each patient continues moving toward their goals at a safe, sustainable pace
David Hornigold, Jacqueline Naylor and Alessandra Rossi (MedImmune, Cambridge, UK), and used as described elsewhere(38)
Research Articles on Glutathione S Transferase Alpha 1 (GSTA1) Related Products